dc.creatorSteinman, Gary
dc.date.accessioned2020-08-21T20:08:17Z
dc.date.accessioned2022-09-23T18:14:47Z
dc.date.available2020-08-21T20:08:17Z
dc.date.available2022-09-23T18:14:47Z
dc.date.created2020-08-21T20:08:17Z
dc.identifier0306-9877
dc.identifierhttps://doi.org/10.1016/j.mehy.2020.109797
dc.identifierhttp://hdl.handle.net/20.500.12010/12108
dc.identifierhttps://doi.org/10.1016/j.mehy.2020.109797
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3497943
dc.description.abstractThe current pandemic of Covid-19 has created a paradigm for possibly gaining greater insight in two conditions: 1) Inflammatory maladies in pregnancy, and. 2) The biology of IGF-1 in autism. Studies since the beginning of this century have supported the view that IGF-1 deficiency in the neonate defines the basis of autism. As a result, it appears that interleukin-6 in corona virus-based infections causes reduced defenses because of suppressed IGF-1, especially in older patients. This may also portend an increase of autism in the offspring of gravidas currently affected severely by Covid-19.
dc.languageeng
dc.publisherMedical Hypotheses
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.rightsAcceso restringido
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectCOVID-19
dc.subjectAutism
dc.titleCOVID-19 and autism


Este ítem pertenece a la siguiente institución